DNASE1L3基因Arg206Cys错义突变导致蛋白分泌缺陷并增加系统性红斑狼疮风险
该研究通过条件分析验证DNASE1L3/PXK基因座与SLE的关联是否由rs35677470(Arg206Cys)驱动,并在HEK293细胞和单核细胞来源树突状细胞中检测蛋白分泌。结果显示rs35677470可解释该基因座的主要SLE风险信号,206Cys变异保留酶活性但分泌显著减少,提示分泌缺陷而非酶功能丧失是风险机制。
要点
- rs35677470(Arg206Cys)是DNASE1L3基因座SLE风险关联的关键变异。
- 206Cys变异保留DNase酶活性但蛋白分泌显著减少。
- 杂合风险OR=1.14、纯合风险OR=1.68,提示部分酶功能保留。
核心结论
- DNASE1L3基因座的SLE风险关联依赖于错义SNP rs35677470,该变异导致DNASE1L3蛋白分泌减少但不消除其DNase酶功能。
研究设计与样本
- 对来自SLE Immunochip研究的欧洲裔病例和对照进行rs35677470的条件分析,并比较基因型和单倍型频率。
- 在表达重组和内源性206Arg与206Cys蛋白变异的HEK293细胞和单核细胞来源树突状细胞中检测DNASE1L3蛋白水平。
主要发现
- 对rs35677470条件分析消除了领先SNP rs180977001和rs73081554的SLE风险关联信号,二者与rs35677470标记同一风险单倍型。
- SLE风险基因型效应量适中:杂合风险OR=1.14,纯合风险等位基因OR=1.68,提示部分DNASE1L3核酸内切酶功能保留。
- 对rs35677470条件分析后,PXK基因的SLE保护信号(领先SNP rs11130643)仍存在。
- DNASE1L3 206Cys风险变异保留酶活性,但人工和内源性DNASE1L3 206Cys蛋白的分泌显著减少。
关键数值与推荐
- 杂合风险OR=1.14,纯合风险等位基因OR=1.68(SLE风险基因型效应量)。
- 领先SNP rs180977001和rs73081554与rs35677470标记同一风险单倍型。
- PXK领先SNP rs11130643在条件分析后仍显示SLE保护信号。
临床怎么用
- 对于携带DNASE1L3 rs35677470风险等位基因的个体,可关注其DNASE1L3蛋白分泌缺陷而非酶活性丧失的潜在病理意义。
- 该发现支持DNASE1L3分泌减少作为SLE风险机制,但尚未提供临床干预建议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine if the polymorphism encoding the Arg206Cys substitution in DNASE1L3 explains the association of the DNASE1L3/PXK gene locus with systemic lupus erythematosus (SLE) and to examine the effect of the Arg206Cys sequence change on DNASE1L3 protein function. METHODS: Conditional analysis for rs35677470 was performed on cases and controls with European ancestry from the SLE Immunochip study, and genotype and haplotype frequencies were compared. DNASE1L3 protein levels were measured in cells and supernatants of HEK293 cells and monocyte-derived dendritic cells expressing recombinant and endogenous 206Arg and 206Cys protein variants. RESULTS: Conditional analysis on rs35677470 eliminated the SLE risk association signal for lead single-nucleotide polymorphisms (SNPs) rs180977001 and rs73081554, which are found to tag the same risk haplotype as rs35677470. The modest effect sizes of the SLE risk genotypes (heterozygous risk OR=1.14 and homozygous risk allele OR=1.68) suggest some DNASE1L3 endonuclease enzyme function is retained. An SLE protective signal in PXK (lead SNP rs11130643) remained following conditioning on rs35677470. The DNASE1L3 206Cys risk variant maintained enzymatic activity, but secretion of the artificial and endogenous DNASE1L3 206Cys protein was substantially reduced. CONCLUSIONS: SLE risk association in the DNASE1L3 locus is dependent on the missense SNP rs35677470, which confers a reduction in DNASE1L3 protein secretion but does not eliminate its DNase enzyme function.
引用
- Coke LN, Wen H, Comeau M, et al. Arg206Cys substitution in DNASE1L3 causes a defect in DNASE1L3 protein secretion that confers risk of systemic lupus erythematosus. Ann Rheum Dis. 2021. PMID: 33455918. doi:10.1136/annrheumdis-2020-218810
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。